Skip to content

Jazz Pharmaceuticals JAZZ Other Countries — PP&E (Net)

Discontinued — last reported Q4 '18

Similar metrics at other companies

Chart Industries logo
GTLSOther Non U.S.Countries — Property, plant and equipment, net
$122.7M+14.1%
Fair Isaac logo
FICOOther Country — PP&E (Net)
$8.27M+15.3%
Gilead Sciences logo
GILDNon-US — Property, plant and equipment, net
$631M+0.6%
Zimmer Biomet Holdings logo
ZBHOthers Countries — PP&E (Net)
$790.5M-0.6%
General Electric logo
GEOther Global — Property, plant and equipment – net (Note 6)
$11M-8.3%
Lattice Semiconductor logo
LSCCForeign Countries — PP&E (Net)
$37.35M+32.5%

Other financials

Income statement

See full
Revenue$1.1B+19.1%
Operating income$336.6M+702%
Net income$293.1M+417%
EPS (diluted)$4.43+391%

Balance sheet

See full
Cash & equivalents$667.5M-64.1%
Total debt$5.4B-0.1%
Total equity$4.5B+8.6%
Total assets$11.9B+2.8%

Cash flow

See full
Operating cash flow$408.2M-5.0%
CapEx$19.7M+41.7%
Free cash flow$388.5M-6.6%

Valuation

See full
Market cap$14.11B+54.4%
Enterprise value$18.85B+47.7%
P/S3.2×+0.9×

Profitability

See full
Operating margin-11.9%-28.1pp
Net margin-8.9%-20.5pp
FCF margin28.6%-8.6pp

Returns & leverage

See full
Return on equity-9.1%-21.2pp
Debt / equity1.2×-0.1×
Current ratio-1.3×

Where this comes from

Reported directly by Jazz Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Jazz Pharmaceuticals’s 10-K, filed February 25, 2020, on SEC EDGAR. View the filing →

Questions, answered.

What does other countries — PP&E (net) mean?
The net value of the company's physical assets, like buildings and equipment, located in international regions outside of its main operating markets.
How do you interpret other countries — PP&E (net)?
An increase suggests expansion of international manufacturing or operational capacity, while a decrease may indicate asset divestiture, depreciation, or a shift toward third-party logistics in those regions.
How does other countries — PP&E (net) compare across companies?
Peers in the biopharmaceutical industry typically report similar geographic breakdowns of property, plant, and equipment to demonstrate their global manufacturing and distribution reach.